open access

Vol 59, No 2 (2008)
Review paper
Submitted: 2013-02-15
Published online: 2008-05-08
Get Citation

Postpartum thyroiditis - current views on unappreciated disease

Robert Krysiak, Bogdan Marek, Bogusław Okopień
Endokrynol Pol 2008;59(2):180-190.

open access

Vol 59, No 2 (2008)
Reviews — Postgraduate Education
Submitted: 2013-02-15
Published online: 2008-05-08

Abstract

Postpartum thyroiditis is a form of autoimmune thyroiditis developing during the first 12 months postpartum as a consequence of the immunologic flare following the immune suppression of pregnancy. This disease, found in 5-10% of women in a general population and even more frequently in patients suffering from other autoimmune disorders, may reoccur in about 70% of women after a subsequent pregnancy. Postpartum thyroiditis is strongly associated with antithyroid peroxidase antibodies. Patients may present with symptoms of either thyrotoxicosis or hypothyroidism which may be transient or, in some (20-30%) cases of hypothyroidism, permanent in nature. A thyrotoxic phase of postpartum thyroiditis is usually brief and often unnoticed before a more long-lasting hypothyroid phase occurs. The diagnosis of postpartum thyroiditis is based on the observation of abnormal thyroid function tests in a postpartum antithyroid peroxidase- positive woman. In this paper, we discuss the etiopathogenesis, clinical picture, diagnosis, prognosis and treatment of postpartum thyroiditis and provide the reader with some practical guidance concerning dealing with a patient suffering from this disorder. (Pol J Endocrinol 2008; 59 (2): 180-189)

Abstract

Postpartum thyroiditis is a form of autoimmune thyroiditis developing during the first 12 months postpartum as a consequence of the immunologic flare following the immune suppression of pregnancy. This disease, found in 5-10% of women in a general population and even more frequently in patients suffering from other autoimmune disorders, may reoccur in about 70% of women after a subsequent pregnancy. Postpartum thyroiditis is strongly associated with antithyroid peroxidase antibodies. Patients may present with symptoms of either thyrotoxicosis or hypothyroidism which may be transient or, in some (20-30%) cases of hypothyroidism, permanent in nature. A thyrotoxic phase of postpartum thyroiditis is usually brief and often unnoticed before a more long-lasting hypothyroid phase occurs. The diagnosis of postpartum thyroiditis is based on the observation of abnormal thyroid function tests in a postpartum antithyroid peroxidase- positive woman. In this paper, we discuss the etiopathogenesis, clinical picture, diagnosis, prognosis and treatment of postpartum thyroiditis and provide the reader with some practical guidance concerning dealing with a patient suffering from this disorder. (Pol J Endocrinol 2008; 59 (2): 180-189)
Get Citation

Keywords

postpartum thyroiditis; etiopathogenesis; symptoms; diagnosis; treatment; prevention; recommendations

About this article
Title

Postpartum thyroiditis - current views on unappreciated disease

Journal

Endokrynologia Polska

Issue

Vol 59, No 2 (2008)

Article type

Review paper

Pages

180-190

Published online

2008-05-08

Page views

775

Article views/downloads

5222

Bibliographic record

Endokrynol Pol 2008;59(2):180-190.

Keywords

postpartum thyroiditis
etiopathogenesis
symptoms
diagnosis
treatment
prevention
recommendations

Authors

Robert Krysiak
Bogdan Marek
Bogusław Okopień

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl